About
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India.
Key Metrics
as of Sep 2026Market Cap569 Cr
P/E35.50
Div Yield0.00 %
Book Value₹57.20
52w High₹111.00
52w Low₹49.50
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 73.42 | 65.30 | 54.74 | 45.99 | 51.01 | 57.77 | 35.23 | 21.48 | 18.88 | 30.58 | 40.52 | 59.55 | 51.41 |
| Expenses | 60.92 | 60.79 | 54.50 | 45.93 | 48.65 | 53.94 | 34.61 | 28.21 | 21.27 | 35.11 | 46.83 | 60.94 | 47.59 |
| Operating Profit | 12.50 | 4.51 | 0.24 | 0.06 | 2.36 | 3.83 | 0.62 | -6.73 | -2.39 | -4.53 | -6.31 | -1.39 | 3.82 |
| OPM % | 17.03 | 6.91 | 0.44 | 0.13 | 4.63 | 6.63 | 1.76 | -31.33 | -12.66 | -14.81 | -15.57 | -2.33 | 7.43 |
| Other Income | 0.85 | 0.77 | 0.61 | 0.85 | 0.67 | 0.65 | 0.67 | 1.93 | 2.17 | 2.50 | 1.78 | 2.96 | 2.44 |
| Depreciation | 0.55 | 0.52 | 0.72 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.50 | 0.50 | 0.49 | 0.49 | 0.46 |
| Interest | 0.08 | 0.02 | 0.03 | 0.14 | 0.07 | 0.05 | 0.06 | 0.01 | 0.05 | 0.02 | 0.02 | 0.02 | 0.02 |
| Profit before tax | 12.72 | 4.74 | 0.10 | 0.26 | 2.45 | 3.92 | 0.72 | -5.32 | -0.77 | -2.55 | -5.04 | 1.06 | 5.78 |
| Tax % | 25.55 | 25.32 | 80.00 | 34.62 | 25.71 | 17.60 | -122.22 | 12.41 | 31.17 | -52.16 | -30.75 | 25.47 | 26.12 |
| Net Profit | 9.48 | 3.53 | 0.03 | 0.17 | 1.82 | 3.24 | 1.60 | -5.98 | -1.01 | -1.22 | -3.50 | 0.79 | 4.27 |
| EPS in Rs | 1.75 | 0.65 | 0.01 | 0.03 | 0.34 | 0.60 | 0.29 | -1.10 | -0.19 | -0.22 | -0.64 | 0.19 | 1.05 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Sales | 217.00 | 133.00 | 182.00 | 334.00 | 292.00 | 182.00 |
| Expenses | 210.00 | 138.00 | 190.00 | 299.00 | 249.00 | 132.00 |
| Operating Profit | 7.00 | -5.00 | -8.00 | 35.00 | 42.00 | 50.00 |
| OPM % | 3.30 | -3.50 | -4.60 | 11.00 | 15.00 | 27.00 |
| Other Income | 3.00 | 5.00 | 10.00 | 5.00 | 2.00 | 1.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 |
| Depreciation | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 |
| Profit before tax | 8.00 | -1.00 | -1.00 | 38.00 | 42.00 | 47.00 |
| Tax % | 26.00 | 49.00 | -145.00 | 24.00 | 34.00 | 35.00 |
| Net Profit | 6.00 | -2.00 | 0.00 | 29.00 | 28.00 | 31.00 |
| EPS in Rs | 1.02 | -0.40 | 0.06 | 7.13 | 13.48 | — |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Equity Capital | 54.00 | 43.00 | 43.00 | 33.00 | 16.00 | 10.00 |
| Reserves | 265.00 | 191.00 | 193.00 | 68.00 | 55.00 | 78.00 |
| Borrowings | 1.00 | 60.00 | 60.00 | 60.00 | 61.00 | 1.00 |
| Other Liabilities | 65.00 | 23.00 | 28.00 | 52.00 | 49.00 | 17.00 |
| Total Liabilities | 386.00 | 317.00 | 325.00 | 213.00 | 182.00 | 106.00 |
| Fixed Assets | 30.00 | 30.00 | 32.00 | 30.00 | 22.00 | 20.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 |
| Investments | 191.00 | 165.00 | 119.00 | 34.00 | 0.00 | 0.00 |
| Other Assets | 165.00 | 122.00 | 174.00 | 149.00 | 158.00 | 87.00 |
| Total Assets | 386.00 | 317.00 | 325.00 | 213.00 | 182.00 | 106.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | -14.00 | -22.00 | 49.00 | 23.00 | 2.00 | 9.00 |
| Cash from Investing Activity | -8.00 | 25.00 | -183.00 | -21.00 | -12.00 | -17.00 |
| Cash from Financing Activity | 20.00 | 0.00 | 136.00 | -2.00 | 6.00 | 11.00 |
| Net Cash Flow | -2.00 | 3.00 | 2.00 | 0.00 | -4.00 | 4.00 |
| Free Cash Flow | -15.00 | -22.00 | 45.00 | 16.00 | -5.00 | 7.00 |
| CFO/OP % | -178.00 | 537.00 | -569.00 | 91.00 | 40.00 | 51.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Debtor Days | 140.00 | 197.00 | 92.00 | 97.00 | 139.00 | 85.00 |
| Inventory Days | 45.00 | 12.00 | 22.00 | 17.00 | 25.00 | 18.00 |
| Days Payable | 117.00 | 61.00 | 54.00 | 62.00 | 72.00 | 37.00 |
| Cash Conversion Cycle | 67.00 | 149.00 | 60.00 | 52.00 | 91.00 | 66.00 |
| Working Capital Days | 202.00 | 194.00 | 97.00 | 106.00 | 109.00 | 102.00 |
| ROCE % | 3.00 | -1.00 | -2.00 | 26.00 | 38.00 | — |
Corporate Actions
2 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Rights | 18 Jul 2025 | 19 Jul 2025 | 1:4 | — | |
| Other | 18 Jul 2025 | 19 Jul 2025 | — | — | Right Issue of Equity Shares |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update3 Sep from fitch
-
Rating update30 Jun from crisil
-
Rating update18 Nov 2025 from crisil
-
Rating update10 Oct 2025 from crisil
-
Rating update25 Jun 2025 from fitch
-
Rating update18 Feb 2025 from crisil